Related Experiment Videos
Suppressor T-cells in BCG-infected mice.
Infection and Immunity
|August 1, 1979
Summary
BCG Pasteur infection in mice led to spleen cell suppression and anergy at high doses, but lacked suppressor T-cells in low-dose aerogenic infections. Tuberculin hypersensitivity correlated with BCG dose and spleen cell activity.
Area of Science:
- Immunology
- Microbiology
- Infectious Diseases
Background:
- Bacille Calmette-Guérin (BCG) Pasteur is used to prevent tuberculosis.
- Understanding BCG-induced immune responses is crucial for vaccine development.
Purpose of the Study:
- To investigate the relationship between BCG dose, immune response, and tuberculin hypersensitivity in mice.
- To identify mechanisms of immunosuppression during BCG infection.
Main Methods:
- Mice were infected with varying doses of BCG Pasteur (high, moderate, low).
- BCG growth, tuberculin hypersensitivity, and spleen cell blast transformation were monitored over 90 days.
- Cell mixing studies and antibody treatments were used to identify suppressor cells.
Main Results:
- High and moderate BCG doses induced transient spleen cell activation followed by suppression and anergy to purified protein derivative (PPD).
- Anergic mice had PPD-specific suppressor T-cells, sensitive to anti-Thy-1 treatment.
- Low-dose aerogenic infection caused PPD unresponsiveness without detectable suppressor T-cells, suggesting a lack of sensitized T-cells.
Conclusions:
- BCG dose influences the development of immunosuppression and anergy.
- Suppressor T-cells play a role in BCG-induced anergy at higher infection doses.
- Low-dose aerogenic BCG infection may lead to unresponsiveness via T-cell deficiency rather than active suppression.